Nutrien Prices Offering of an Aggregate of US$1.5 Billion of 5-Year and 30-Year Senior Notes Phosphate Investing
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update Phosphate Investing
SAGE POTASH CORP. IDENTIFIES LARGE-SCALE, HIGH-GRADE, US-BASED POTASH RESOURCE AND COMMENCES TRADING ON THE TSX-V UNDER THE SYMBOL "SAGE" Potash Investing
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update Phosphate Investing
Nutrien Releases 2023 ESG Report, Updating Progress Towards Value-Driven Sustainability Initiatives Phosphate Investing
Nutrien Ag Solutions Grows Commitment to Safety and Sustainability with Samsara's Connected Operations Cloud Phosphate Investing
Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program Phosphate Investing
Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON Injection from U.S. Centers for Medicare & Medicaid Services Phosphate Investing
